0001094084 false 12/31 2022 Q1 0 0 0001094084 2022-01-01 2022-03-31 0001094084 2022-04-30 0001094084 2022-03-31 0001094084 2021-12-31 0001094084 us-gaap:SeriesAPreferredStockMember 2022-03-31 0001094084 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001094084 us-gaap:SeriesBPreferredStockMember 2022-03-31 0001094084 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001094084 us-gaap:ProductMember 2022-01-01 2022-03-31 0001094084 us-gaap:ProductMember 2021-01-01 2021-03-31 0001094084 TKOI:RecurringMember 2022-01-01 2022-03-31 0001094084 TKOI:RecurringMember 2021-01-01 2021-03-31 0001094084 2021-01-01 2021-03-31 0001094084 TKOI:PreferredStockSeriesAMember 2020-12-31 0001094084 TKOI:PreferredStockSeriesBMember 2020-12-31 0001094084 us-gaap:CommonStockMember 2020-12-31 0001094084 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001094084 us-gaap:RetainedEarningsMember 2020-12-31 0001094084 2020-12-31 0001094084 TKOI:PreferredStockSeriesAMember 2021-12-31 0001094084 TKOI:PreferredStockSeriesBMember 2021-12-31 0001094084 us-gaap:CommonStockMember 2021-12-31 0001094084 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001094084 us-gaap:RetainedEarningsMember 2021-12-31 0001094084 TKOI:PreferredStockSeriesAMember 2021-01-01 2021-03-31 0001094084 TKOI:PreferredStockSeriesBMember 2021-01-01 2021-03-31 0001094084 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001094084 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001094084 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001094084 TKOI:PreferredStockSeriesAMember 2022-01-01 2022-03-31 0001094084 TKOI:PreferredStockSeriesBMember 2022-01-01 2022-03-31 0001094084 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001094084 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001094084 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001094084 TKOI:PreferredStockSeriesAMember 2021-03-31 0001094084 TKOI:PreferredStockSeriesBMember 2021-03-31 0001094084 us-gaap:CommonStockMember 2021-03-31 0001094084 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001094084 us-gaap:RetainedEarningsMember 2021-03-31 0001094084 2021-03-31 0001094084 TKOI:PreferredStockSeriesAMember 2022-03-31 0001094084 TKOI:PreferredStockSeriesBMember 2022-03-31 0001094084 us-gaap:CommonStockMember 2022-03-31 0001094084 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001094084 us-gaap:RetainedEarningsMember 2022-03-31 0001094084 TKOI:VdaPurchaseAgreementMember 2021-08-01 2021-08-06 0001094084 2021-01-01 2021-12-31 0001094084 us-gaap:ProductMember TKOI:HospitalityMember 2022-01-01 2022-03-31 0001094084 us-gaap:ProductMember TKOI:EducationMember 2022-01-01 2022-03-31 0001094084 us-gaap:ProductMember TKOI:MultipleDwellingUnitsMember 2022-01-01 2022-03-31 0001094084 us-gaap:ProductMember TKOI:Government1Member 2022-01-01 2022-03-31 0001094084 us-gaap:ProductMember TKOI:Healthcare1Member 2022-01-01 2022-03-31 0001094084 TKOI:RecurringIncomeMember TKOI:HospitalityMember 2022-01-01 2022-03-31 0001094084 TKOI:RecurringIncomeMember TKOI:EducationMember 2022-01-01 2022-03-31 0001094084 TKOI:RecurringIncomeMember TKOI:MultipleDwellingUnitsMember 2022-01-01 2022-03-31 0001094084 TKOI:RecurringIncomeMember TKOI:Government1Member 2022-01-01 2022-03-31 0001094084 TKOI:RecurringIncomeMember TKOI:Healthcare1Member 2022-01-01 2022-03-31 0001094084 TKOI:RecurringIncomeMember 2022-01-01 2022-03-31 0001094084 TKOI:HospitalityMember 2022-01-01 2022-03-31 0001094084 TKOI:EducationMember 2022-01-01 2022-03-31 0001094084 TKOI:MultipleDwellingUnitsMember 2022-01-01 2022-03-31 0001094084 TKOI:Government1Member 2022-01-01 2022-03-31 0001094084 TKOI:Healthcare1Member 2022-01-01 2022-03-31 0001094084 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember TKOI:HospitalityMember 2022-01-01 2022-03-31 0001094084 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember TKOI:EducationMember 2022-01-01 2022-03-31 0001094084 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember TKOI:MultipleDwellingUnitsMember 2022-01-01 2022-03-31 0001094084 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember TKOI:Government1Member 2022-01-01 2022-03-31 0001094084 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember TKOI:Healthcare1Member 2022-01-01 2022-03-31 0001094084 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember TKOI:AllSegmentsMember 2022-01-01 2022-03-31 0001094084 us-gaap:ProductMember TKOI:HospitalityMember 2021-01-01 2021-03-31 0001094084 us-gaap:ProductMember TKOI:EducationMember 2021-01-01 2021-03-31 0001094084 us-gaap:ProductMember TKOI:MultipleDwellingUnitsMember 2021-01-01 2021-03-31 0001094084 us-gaap:ProductMember TKOI:Government1Member 2021-01-01 2021-03-31 0001094084 us-gaap:ProductMember TKOI:Healthcare1Member 2021-01-01 2021-03-31 0001094084 TKOI:RecurringIncomeMember TKOI:HospitalityMember 2021-01-01 2021-03-31 0001094084 TKOI:RecurringIncomeMember TKOI:EducationMember 2021-01-01 2021-03-31 0001094084 TKOI:RecurringIncomeMember TKOI:MultipleDwellingUnitsMember 2021-01-01 2021-03-31 0001094084 TKOI:RecurringIncomeMember TKOI:Government1Member 2021-01-01 2021-03-31 0001094084 TKOI:RecurringIncomeMember TKOI:Healthcare1Member 2021-01-01 2021-03-31 0001094084 TKOI:RecurringIncomeMember 2021-01-01 2021-03-31 0001094084 TKOI:HospitalityMember 2021-01-01 2021-03-31 0001094084 TKOI:EducationMember 2021-01-01 2021-03-31 0001094084 TKOI:MultipleDwellingUnitsMember 2021-01-01 2021-03-31 0001094084 TKOI:Government1Member 2021-01-01 2021-03-31 0001094084 TKOI:Healthcare1Member 2021-01-01 2021-03-31 0001094084 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember TKOI:HospitalityMember 2021-01-01 2021-03-31 0001094084 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember TKOI:EducationMember 2021-01-01 2021-03-31 0001094084 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember TKOI:MultipleDwellingUnitsMember 2021-01-01 2021-03-31 0001094084 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember TKOI:Government1Member 2021-01-01 2021-03-31 0001094084 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember TKOI:Healthcare1Member 2021-01-01 2021-03-31 0001094084 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember TKOI:AllSegmentsMember 2021-01-01 2021-03-31 0001094084 TKOI:HeritageBankMember us-gaap:RevolvingCreditFacilityMember 2014-09-30 0001094084 TKOI:HeritageBankMember us-gaap:RevolvingCreditFacilityMember 2021-12-31 0001094084 TKOI:HeritageBankMember us-gaap:RevolvingCreditFacilityMember 2022-01-01 2022-03-31 0001094084 TKOI:HeritageBankMember us-gaap:RevolvingCreditFacilityMember 2021-01-01 2021-12-31 0001094084 TKOI:HeritageBankMember us-gaap:RevolvingCreditFacilityMember 2014-01-01 2014-10-09 0001094084 TKOI:HeritageBankMember us-gaap:RevolvingCreditFacilityMember 2014-10-09 0001094084 TKOI:HeritageBankMember us-gaap:RevolvingCreditFacilityMember 2019-11-02 2019-11-06 0001094084 TKOI:HeritageBankMember us-gaap:RevolvingCreditFacilityMember 2019-11-06 0001094084 TKOI:HeritageBankMember us-gaap:RevolvingCreditFacilityMember 2022-03-31 0001094084 TKOI:HeritageBankMember us-gaap:RevolvingCreditFacilityMember 2022-03-01 2022-03-10 0001094084 TKOI:PPPLoanMember 2020-04-17 0001094084 TKOI:PPPLoanMember 2021-02-15 2021-02-16 0001094084 TKOI:PPPLoan2Member 2021-09-14 2021-09-15 0001094084 us-gaap:SeriesAPreferredStockMember 2009-11-16 0001094084 2009-11-01 2009-11-16 0001094084 2009-11-16 0001094084 us-gaap:SeriesBPreferredStockMember 2010-08-04 0001094084 2010-08-04 0001094084 us-gaap:SeriesBPreferredStockMember 2010-08-01 2010-08-04 0001094084 us-gaap:SeriesBPreferredStockMember 2011-04-01 2011-04-08 0001094084 2010-08-01 2010-08-04 0001094084 TKOI:Plan2020Member 2022-03-31 0001094084 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0001094084 us-gaap:EmployeeStockOptionMember TKOI:ExercisePrice1Member 2022-03-31 0001094084 us-gaap:EmployeeStockOptionMember TKOI:ExercisePrice1Member 2022-01-01 2022-03-31 0001094084 us-gaap:EmployeeStockOptionMember TKOI:ExercisePrice2Member 2022-03-31 0001094084 us-gaap:EmployeeStockOptionMember TKOI:ExercisePrice2Member 2022-01-01 2022-03-31 0001094084 us-gaap:EmployeeStockOptionMember 2022-03-31 0001094084 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001094084 us-gaap:EmployeeStockOptionMember 2020-12-31 0001094084 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001094084 us-gaap:EmployeeStockOptionMember 2021-12-31 0001094084 us-gaap:WarrantMember 2020-12-31 0001094084 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001094084 us-gaap:WarrantMember 2021-12-31 0001094084 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001094084 us-gaap:WarrantMember 2022-03-31 0001094084 TKOI:NonEmployeeDirectorsMember 2022-01-01 2022-03-31 0001094084 TKOI:NonEmployeeDirectorsMember 2021-01-01 2021-03-31 0001094084 TKOI:WaukeshaOfficeMember 2022-03-31 0001094084 TKOI:WaukeshaOfficeMember 2022-01-01 2022-03-31 0001094084 TKOI:WaukeshaFloorMember 2022-03-31 0001094084 TKOI:GaithersburgMember 2022-03-31 0001094084 TKOI:MrGramagliaMember 2022-01-01 2022-03-31 0001094084 TKOI:MrSobieskisMember 2022-01-01 2022-03-31 0001094084 TKOI:MrMushrushsMember 2022-01-01 2022-03-31 0001094084 us-gaap:SalesRevenueNetMember TKOI:ThreeCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001094084 us-gaap:SalesRevenueNetMember TKOI:TwoCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0001094084 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember TKOI:ThreeCustomersMember 2022-01-01 2022-03-31 0001094084 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember TKOI:FiveCustomersMember 2021-01-01 2021-12-31 0001094084 TKOI:PurchasesMember us-gaap:SupplierConcentrationRiskMember TKOI:TwoSuppliersMember 2022-01-01 2022-03-31 0001094084 TKOI:PurchasesMember us-gaap:SupplierConcentrationRiskMember TKOI:TwoSuppliersMember 2021-01-01 2021-03-31 0001094084 TKOI:OneSupplierMember 2022-03-31 0001094084 TKOI:OneSupplierMember 2021-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft

Table of Contents

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2022

 

OR

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the transition period from __________ to __________.

 

Commission file number 001-31972

 

TELKONET, INC.

(Exact name of Registrant as specified in its charter)

 

Utah 87-0627421
(State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.)
   
20800 Swenson Drive, Suite 175, Waukesha, WI 53186
(Address of Principal Executive Offices) (Zip Code)

 

(414) 302-2299

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
None None None

 

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act. Yes ☐ No

 

The number of shares outstanding of the registrant’s common stock, par value $0.001 per share, as of April 30, 2022 is 299,212,282.

 

 

   

 

 

 

TELKONET, INC.

FORM 10-Q

March 31, 2022

 

Index

 

  Page
   
PART I. FINANCIAL INFORMATION 3
   
Item 1. Financial Statements 3
   
Condensed Consolidated Balance Sheets (Unaudited): March 31, 2022 and December 31, 2021 3
   
Condensed Consolidated Statement of Operations (Unaudited):Three Months Ended March 31, 2022 and 2021 4
   
Condensed Consolidated Statement of Stockholders’ Equity (Unaudited): January 1, through March 31, 2022 and 2021 5
   
Condensed Consolidated Statements of Cash Flows (Unaudited): Three Months Ended March 31, 2022 and 2021 7
   
Notes to Condensed Consolidated Financial Statements (Unaudited) 8
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 25
   
Item 3. Quantitative and qualitative disclosures about market risk 30
   
Item 4. Controls and Procedures 31
   

 

PART II. OTHER INFORMATION

 

33

   
Item 1. Legal Proceedings 33
   
Item 1A. Risk Factors 33
   
Item 2. Unrestricted sales of equity securities and use of proceeds 33
   
Item 3. Defaults upon senior securities 33
   
Item 4. Mine safety disclosures 33
   
Item 5. Other information 33
   
Item 6. Exhibits 33

 

 

 

 2 

 

 

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

TELKONET, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

         
  

March 31,

2022

  

December 31,

2021

 
ASSETS          
Current assets:          
Cash and cash equivalents  $5,878,897   $2,361,059 
Accounts receivable, net   1,965,244    1,010,554 
Inventories, net   1,074,952    825,559 
Contract assets   128,872    266,014 
Prepaid expenses   464,165    735,092 
Total current assets   9,512,130    5,198,278 
           
Property and equipment, net   74,749    84,201 
           
Other assets:          
Deposits   7,595    7,595 
Operating lease right of use assets   536,114    570,512 
Total other assets   543,709    578,107 
           
Total Assets  $10,130,588   $5,860,586 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable  $1,623,486   $1,865,535 
Accrued liabilities   817,511    718,721 
Line of credit   436,136    403,089 
Contract liabilities – current   815,478    800,965 
Operating lease liabilities – current   145,409    195,176 
Income taxes payable   5,431    5,431 
Total current liabilities   3,843,451    3,988,917 
           
Long-term liabilities:          
Contract liabilities – long-term   125,624    140,265 
Operating lease liabilities – long-term   470,591    459,668 
Accrued royalties – long-term   325,000    360,000 
Total long-term liabilities   921,215    959,933 
Total liabilities  $4,764,666   $4,948,850 
           
Commitments and contingencies        
Stockholders’ Equity          
Preferred Stock Series A, par value $.001 per share; 215 shares designated, 181 shares outstanding at March 31, 2022 and 185 outstanding at December 31, 2021, preference in liquidation of $1,800,887 and $1,822,450 as of March 31, 2022 and December 31, 2021, respectively.   1,310,765    1,340,566 
Preferred Stock Series B, par value $.001 per share; 567 shares designated, 52 shares outstanding at March 31, 2022 and December 31, 2021, preference in liquidation of $502,740 and $497,605 as of March 31, 2022 and December 31, 2021 respectively.   362,059    362,059 
Common Stock, par value $.001 per share; 475,000,000 shares authorized; 299,212,282 and 136,311,335 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively.   299,212    136,311 
Additional paid-in-capital   132,579,890    127,740,976 
Accumulated deficit   (129,186,004)   (128,668,176)
Total stockholders’ equity   5,365,922    911,736 
           
Total Liabilities and Stockholders’ Equity  $10,130,588   $5,860,586 

 

See accompanying notes to the unaudited condensed consolidated financial statements

 

 

 3 

 

  

TELKONET, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

           
   For the Three Months Ended 
   March 31, 
   2022   2021 
Revenues, net:          
Product  $1,954,430   $1,107,864 
Recurring   196,275    186,345 
Total Net Revenue   2,150,705    1,294,209 
           
Cost of Sales:          
Product   1,132,900    577,814 
Recurring   31,770    10,900 
Total Cost of Sales   1,164,670    588,714 
           
Gross Profit   986,035    705,495 
           
Operating Expenses:          
Research and development   269,240    311,448 
Selling, general and administrative   1,212,813    1,211,103 
Depreciation and amortization   9,453    13,240 
Total Operating Expenses   1,491,506    1,535,791 
           
Operating Loss   (505,471)   (830,296)
           
Other Income (Expenses):          
Gain / (Loss) on debt extinguishment       920,673 
Interest expense, net   (12,357)   (7,873)
Total Other Income (Expenses)   (12,357)   912,800 
           
Income (Loss) before Provision for Income Taxes   (517,828)   82,504 
Income Taxes Provision (Benefit)       (235)
Net Income (Loss)  $(517,828)  $82,739 
           
Net Income (Loss) per Common Share:          
Basic – Net Income (Loss) Attributable to Common Stockholders  $(0.00)  $0.00 
Diluted – Net Income (Loss) Attributable to Common Stockholders  $(0.00  $0.00 
           
Weighted Average Common Shares Outstanding used in Computing Basic Net Income/Loss Per Share   286,542,208    136,311,335 
Weighted Average Common Shares Outstanding used in Computing Diluted Net Income/Loss Per Share   286,542,208    136,311,335 

 

See accompanying notes to the unaudited condensed consolidated financial statements

 

 

 4 

 

 

TELKONET, INC.

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (UNAUDITED)

JANUARY 1, 2021 THROUGH MARCH 31, 2021

 

                                     
   Series A Preferred Stock   Series A Preferred Stock   Series B
Preferred
Stock
   Series B
Preferred
Stock
   Common   Common
Stock
   Additional
Paid-in
   Accumulated   Total
Stockholders’
 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
Balance at January 1, 2021   185   $1,340,566    52   $362,059    136,311,335   $136,311   $127,733,714   $(128,255,391)  $1,317,259 
                                              
Shares issued to directors                                    
                                              
Stock-based compensation expense related to employee stock options                           1,815        1,815 
                                              
Net profit / (loss) attributable to common stockholders                               82,739    82,739 
Balance at March 31, 2021   185   $1,340,566    52   $362,059    136,311,335   $136,311   $127,735,529    (128,172,652)  $1,401,813 

 

 

See accompanying notes to the unaudited, condensed, consolidated financial statements

 

 

 5 

 

 

TELKONET, INC.

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (UNAUDITED)

JANUARY 1, 2022 THROUGH MARCH 31, 2022

 

   Series A Preferred Stock   Series A Preferred Stock   Series B
Preferred
Stock
   Series B
Preferred
Stock
   Common   Common
Stock
   Additional
Paid-in
   Accumulated   Total
Stockholders’
 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
Balance at January 1, 2022   185   $1,340,566    52   $362,059    136,311,335   $136,311   $127,740,976   $(128,668,176)  $911,736 
                                              
Stock and warrants issued in VDA Transaction                   162,900,947    162,901    4,837,099        5,000,000 
                                              
Repurchase of Series A Preferred Stock Shares   (4)   (29,801)                           (29,801)
                                              
Stock-based compensation expense related to employee stock options                           1,815        1,815 
                                              
Net profit / (loss) attributable to common stockholders                               (517,828)   (517,828)
Balance at March 31, 2022   181   $1,310,765    52   $362,059    299,212,282   $299,212   $132,579,890    (129,186,004)  $5,365,922 

 

 

See accompanying notes to the unaudited, condensed, consolidated financial statements

 

 

 6 

 

  

TELKONET, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

           
   For the Three Months Ended 
   March 31, 
   2022   2021 
Cash Flows from Operating Activities:          
Net income (loss)  $(517,828)  $82,739 
           
Adjustments to reconcile net loss to cash used in operating activities:          
Stock-based compensation expense related to employee stock options   1,815    1,815 
Depreciation and amortization   9,453    13,240 
Noncash operating lease expense   34,398    57,387 
Gain on debt extinguishment       (920,673)
           
Changes in operating assets and liabilities:          
Accounts receivable, net   (954,690)   (142,384)
Inventories, net   (249,394)   223,479 
Prepaid expenses   397,860    (40,951)
Accounts payable   (271,851)   (268,338)
Accrued royalties – long-term   (35,000)   (35,000)
Accrued liabilities   98,790    234,291 
Contract liabilities   (128)   108,580 
Contract assets   10,210    89,520 
Operating lease liabilities   (38,844)   (57,658)
Net Cash Used In Operating Activities   (1,515,209)   (653,953)
           
Cash Flows From Financing Activities:          
Proceeds from stock and warrants issued in VDA Transaction   5,000,000     
Proceeds from line of credit   1,360,000    1,680,000 
Payments on line of credit   (1,326,953)   (1,359,475)
Net Cash Provided By (Used In) Financing Activities   5,033,047    320,525 
           
Net increase (decrease) in cash and cash equivalents   3,517,838    (333,428)
Cash, cash equivalents at the beginning of the period   2,361,059    3,011,811 
Cash and cash equivalents at the end of the period  $5,878,897   $2,678,383 

 

Supplemental Disclosures of Cash Flow Information:        
         
Cash transactions:          
Cash paid during the period for interest  $5,019   $5,875 

 

See accompanying notes to the unaudited condensed consolidated financial statements

 

 

 7 

 

   

TELKONET, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2022

(UNAUDITED)

 

 

NOTE A – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

 

A summary of the significant accounting policies applied in the preparation of the accompanying condensed consolidated financial statements follows.

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements of Telkonet, Inc. (the “Company” or “Telkonet”) have been prepared in accordance with Rule S-X of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

 

In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. However, the results from operations for the three months ended March 31, 2022, are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated December 31, 2021 financial statements and footnotes thereto included in the Company's Form 10-K filed with the SEC.

 

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Telkonet Communications, Inc., operating as a single reportable business segment.

 

Business

 

Telkonet, Inc. (“we,” “us,” “our,” the “Company,” or “Telkonet”), formed in 1999 and incorporated under the laws of the state of Utah, is the creator of the EcoSmart and the Rhapsody Platforms of intelligent automation solutions designed to optimize energy efficiency, comfort and analytics in support of the emerging Internet of Things (“IoT”). The platforms are deployed primarily in the hospitality, educational, governmental and other commercial markets, and is specified by engineers, HVAC professionals, building owners, and building operators. We currently operate in a single reportable business segment.

 

In 2007, the Company acquired substantially all of the assets of Smart Systems International (“SSI”), which was a provider of energy management products and solutions to customers in the United States and Canada and the precursor to the Company’s EcoSmart Platform. In 2020, the Company launched the Rhapsody Platform, which simplifies the installation and setup of the Company’s newest products and integrations. Both platforms provide comprehensive savings, management reporting, analytics and virtual engineering of a customer’s portfolio and/or property’s room-by-room energy consumption. Telkonet has deployed more than a half million intelligent devices worldwide in properties within the hospitality, educational, governmental and other commercial markets. The platforms are recognized as solutions for reducing energy consumption, operational costs and carbon footprints, and eliminating the need for new energy generation in these marketplaces – all whilst improving occupant comfort and convenience.

 

On August 6, 2021, the Company entered into a stock purchase agreement (the “Purchase Agreement”) with VDA Group S.p.A., an Italian joint stock company (“VDA”), pursuant to which VDA would, at the Closing (as defined in the Purchase Agreement), contribute $5 million to Telkonet (the “Financing”) and, in exchange, Telkonet would issue to VDA (The “Issuance”): (i) 162,900,947 shares of Company Common Stock (the “Common Stock”); and (ii) a warrant to purchase 105,380,666 additional shares of Common Stock (the “Warrant”) (the Issuance and the Financing referred to collectively herein as the “VDA Transaction”). The Closing occurred on January 7, 2022.

 

Following the issuance of 162,900,947 shares of Common Stock to VDA upon the Closing, VDA owns 53% of the issued and outstanding Common Stock on a fully diluted as exercised/converted basis, resulting in a change of control of the Company. VDA could eventually own as much as 65% of the issued and outstanding Common Stock on a fully diluted as exercised/converted basis if it fully exercises the Warrant.

 

The Company has elected not to apply pushdown accounting adjustments to the Company’s financial statements related to the change in control as allowed by Accounting Standards Update No. 2014-17.

  

 

 8 

 

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. On an ongoing basis, the Company evaluates significant estimates used in preparing its consolidated financial statements including those related to revenue recognition and allowances for uncollectible accounts receivable, inventory obsolescence, recovery of long-lived assets, income tax provisions and related valuation allowance, stock-based compensation, and contingencies. The Company bases its estimates on historical experience, underlying run rates and various other assumptions that the Company believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from these estimates. The following critical judgments, assumptions, and estimates used in the preparation of the consolidated financial statements are summarized below. Please refer to our most recent 10-K filing for a more in-depth analysis of such policies.

 

Revenue from Contracts with Customers

 

Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606, the Standard”) supersedes nearly all legacy revenue recognition guidance. ASC 606, the Standard outlines a comprehensive five-step revenue recognition model based on the principle that an entity should recognize revenue based on when it satisfies its performance obligations by transferring control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for said goods or services.

 

i)Identify the customer contracts

The Company accounts for a customer contract under ASC 606 when the contract is legally enforceable. A contract is legally enforceable when all of the following criteria are met: (1) the contract has been approved by the Company and the customer and both parties are committed to perform their respective obligations, (2) the Company can identify each party’s rights regarding goods or services transferred, (3) the Company can identify payment terms for goods or services transferred, (4) the contract has commercial substance, and (5) collectability of all the consideration to which the Company is entitled in exchange for the goods or services transferred is probable.

 

A contract does not exist if each party to the contract has the unilateral right to terminate a wholly unperformed contract without compensating the other party (or parties). Nearly all of the Company’s contracts do not contain such mutual termination rights for convenience. All contracts are in written form.

 

ii)Identify the performance obligations

The Company will enter into product only contracts that contain a single performance obligation related to the transfer of products to a customer.

 

The Company will also enter into certain customer contracts that encompass product and installation services, referred to as “turnkey” solutions. These contracts ultimately provide the customer with a solution that enhances the functionality of the customer’s existing equipment. For this reason, the Company has determined that the product and installation services are not separately identifiable performance obligations, but in essence represent one, combined performance obligation (“turnkey”).

 

The Company also offers post-installation support services to customers. Support services are considered a separate performance obligation.

 

iii)Determine the transaction price

The Company generally enters into contracts containing fixed prices. It is not customary for the Company to include contract terms that would result in variable consideration. In the rare situation that a contract does include this type of provision, it is not expected to result in a material adjustment to the transaction price. The Company regularly extends pricing discounts; however, they are negotiated up front and adjust the fixed transaction price set out in the contract.

 

 

 9 

 

 

Customer contracts will typically contain upfront deposits that will be applied against future invoices, as well as customer retainage. The intent of any required deposit or retainage is to ensure that the obligations of either party are honored and follow customary industry practices. In addition, the Company will typically be paid in advance at the beginning of any support contracts, consistent with industry practices. None of these payment provisions are intended to represent significant implicit financing. The Company’s standard payment terms are thirty days from invoice date. Products are fully refundable when returned in their original packaging without damage or defacing less a restocking fee. Historical returns have shown to be immaterial. The Company offers a standard one-year assurance warranty. However customers can purchase an extended warranty. Under the revenue standard, extended warranties are accounted for as a service warranty, requiring the revenue to be recognized over the extended service periods. Contracts involving an extended warranty are immaterial and will continue to be combined with support revenue and recognized on a straight-line basis over the support revenue term.

 

iv)Allocate the transaction price to the performance obligations

Revenues from customer contracts are allocated to the separate performance obligations based on their relative stand-alone selling price (“SSP”) at contract inception. The SSP is the price at which the Company would sell a promised good or service separately. The best evidence of an SSP is the observable price of a good or service when the entity sells that good or service separately in similar circumstances and to similar customers. However, turnkey solutions are sold for a broad range of amounts resulting from, but not limited to, tiered discounting for value added resellers (“VAR”) based upon committed volumes and other economic factors. Due to the high variability of our pricing, the Company cannot establish a reliable SSP using observable data. Accordingly, the Company uses the residual approach to allocate the transaction price to performance obligations related to its turnkey solutions. When support services are not included within the turnkey solution, the residual method is not utilized and no allocation of the transaction price to the performance obligation is necessary.

 

All support service agreements, whether single or multi-year terms, automatically renew for one-year terms at a suggested retail price (“SRP”), unless terminated by either party. Support service renewals are consistently priced and therefore would support the use of SRP as the best estimate of an SSP for such performance obligations.

 

v)Revenue Recognition

The Company recognizes revenues from product only sales at a point in time when control over the product has transferred to the customer. As the Company’s principal terms of sale are FOB shipping point, the Company primarily transfers control and records revenue for product only sales upon shipment.

 

Contract Fulfillment Cost

 

The Company recognizes related costs of the contract over time in relation to the revenue recognition. Costs included within the projects relate to the cost of material, direct labor and costs of outside services utilized to complete projects. These are presented as “Contract assets” in the Consolidated Balance Sheet.

 

Advertising

 

The Company follows the policy of charging the costs of advertising to expenses as incurred. The Company incurred $1,508 and $1,493 in advertising costs during the three months ended March 31, 2022 and 2021, respectively.

 

Research and Development

 

The Company accounts for research and development costs in accordance with the ASC 730-10, “Research and Development”. Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. Total expenditures on research and product development for the three months ended March 31, 2022 and 2021 were $269,240 and $311,448, respectively.

 

 

 10 

 

 

Accounts Receivable

 

Accounts receivable are uncollateralized customer obligations due under normal trade terms. The Company records allowances for doubtful accounts based on customer-specific analysis and general matters such as current assessment of past due balances and economic conditions. The Company writes off accounts receivable when they become uncollectible. Management identifies a delinquent customer based upon the delinquent payment status of an outstanding invoice, generally greater than 30 days past due date. The delinquent account designation does not trigger an accounting transaction until such time the account is deemed uncollectible. The allowance for doubtful accounts is determined by examining the reserve history and any outstanding invoices that are over 30 days past due as of the end of the reporting period. Accounts are deemed uncollectible on a case-by-case basis, at management’s discretion based upon an examination of the communication with the delinquent customer and payment history. Typically, accounts are only escalated to “uncollectible” status after multiple attempts at collection have proven unsuccessful. 

 

Inventory Obsolescence

 

Inventories consist of thermostats, sensors and controllers for Telkonet’s product platforms. These inventories are purchased for resale and do not include manufacturing labor and overhead. Inventories are stated at the lower of cost or net realizable value determined by the first in, first out (FIFO) method. The Company’s inventories are subject to technological obsolescence. Management evaluates the net realizable value of its inventories on a quarterly basis and when it is determined that the Company’s carrying cost of such excess and obsolete inventories cannot be recovered in full, a charge is taken against income for the difference between the carrying cost and the estimated realizable amount. 

 

Guarantees and Product Warranties

 

The Company records a liability for potential warranty claims. The amount of the liability is based on the trend in the historical ratio of claims to sales. The products sold are generally covered by a warranty for a period of one year. In the event the Company determines that its current or future product repair and replacement costs exceed its estimates, an adjustment to these reserves would be charged to earnings in the period such determination is made. 

        
   March 31,
2022
   December 31,
2021
 
         
Beginning balance  $46,650   $17,551 
Warranty claims incurred   (700)   (1,527
Provision charged (credited) to expense   5,468    30,626 
Ending balance  $51,418   $46,650 

 

Income Taxes

 

The Company accounts for income taxes in accordance with ASC 740-10. Under this method, deferred income taxes (when required) are provided based on the difference between the financial reporting and income tax bases of assets and liabilities and net operating losses at the statutory rates enacted for future periods. The Company has a policy of establishing a valuation allowance when it is more likely than not that the Company will not realize the benefits of its deferred income tax assets in the future.

 

The Company follows ASC 740-10-25, which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740-10-25 also provides guidance on de-recognition, classification, treatment of interest and penalties, and disclosure of such positions.

 

 

 11 

 

 

Stock Based Compensation

 

We account for our stock based awards in accordance with ASC 718, which requires a fair value measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors, including employee stock options and restricted stock awards.

 

We estimate the fair value of stock options granted using the Black-Scholes valuation model. This model requires us to make estimates and assumptions including, among other things, estimates regarding the length of time an employee will retain vested stock options before exercising them and the estimated volatility of our common stock price. The fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. Changes in these estimates and assumptions can materially affect the determination of the fair value of stock-based compensation and consequently, the related amount recognized in our consolidated statements of operations.

 

Income (Loss) per Common Share

 

The Company computes earnings per share under ASC 260-10, “Earnings Per Share”. Basic net income (loss) per common share is computed using the weighted average shares outstanding. Diluted net income (loss) per common share is computed using the treasury stock method, which assumes that the proceeds to be received on exercise of outstanding stock options and warrants are used to repurchase shares of the Company at the average market price of the common shares for the year. Dilutive common stock equivalents consist of shares issuable upon the exercise of the Company's outstanding stock options and warrants. For the three months ended March 31, 2022 and 2021, there were 108,704,218 and 3,349,793 shares of common stockrespectively underlying options and warrants excluded due to these instruments being anti-dilutive.

 

Shares used in the calculation of diluted EPS for the first three months of 2022 are summarized below: 

        
   2022   2021 
Net loss  $(517,828)  $82,739 
Less: cumulative dividends earned on Series A and Series B preferred stock   (23,388)   (23,502)
Net loss attributable to common shareholders  $(541,216)  $59,237 

  

Shares used in the calculation of diluted EPS for the quarters ended March 31, 2022 and 2021 are summarized below: 

 

        
   2022   2021 
Weighted average common shares outstanding - basic   286,542,208    136,311,335 
Dilutive effect of stock options        
Dilutive effect of stock warrants        
Weighted average common shares outstanding - diluted   286,542,208    136,311,335 

 

Recovery of Long -Lived Assets

 

We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC 360-10. Recoverability is measured by comparison of the carrying amount to the future net undiscounted cash flows which the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds its fair value.

 

Sales Tax

 

Unless provided with a resale or tax exemption certificate, the Company assesses and collects sales tax on sales transactions and records the amount as a liability. It is recognized as a liability until remitted to the applicable state. Total revenues do not include sales tax as the Company is considered a pass through conduit for collecting and remitting sales taxes.

 

 

 12 

 

 

Concentrations of Credit Risk

 

Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash investments with quality credit institutions. At times, such investments may be in excess of the FDIC insurance limit. The Company has never experienced any losses related to these balances. With respect to trade receivables, the Company performs ongoing credit evaluations of its customers’ financial conditions and limits the amount of credit extended when deemed necessary. The Company provides credit to its customers primarily in the United States in the normal course of business. The Company routinely assesses the financial strength of its customers and, as a consequence, believes its trade receivables credit risk exposure is limited.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid debt instruments purchased with an original maturity date of three months or less to be cash equivalents.

 

Fair Value of Financial Instruments

 

The Company accounts for the fair value of financial instruments in accordance with ASC 820, which defines fair value for accounting purposes, established a framework for measuring fair value and expanded disclosure requirements regarding fair value measurements. Fair value is defined as an exit price, which is the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date. The degree of judgment utilized in measuring the fair value of assets and liabilities generally correlates to the level of pricing observability. Financial assets and liabilities with readily available, actively quoted prices or for which fair value can be measured from actively quoted prices in active markets generally have more pricing observability and require less judgment in measuring fair value. Conversely, financial assets and liabilities that are rarely traded or not quoted have less price observability and are generally measured at fair value using valuation models that require more judgment. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency of the asset, liability or market and the nature of the asset or liability. The Company categorizes financial assets and liabilities that are recurring, at fair value into a three-level hierarchy in accordance with these provisions:

 

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

 

Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; or

 

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and are unobservable.

 

The Company’s financial instruments include cash and cash equivalents, accounts receivable, accounts payable, and certain accrued liabilities. The carrying amounts of these assets and liabilities approximate fair value due to the short maturity of these instruments (Level 1 instruments), except for the line of credit. The carrying amount of the line of credit approximates fair value due to the interest rate and terms approximating those available to the Company for similar obligations (Level 2 instruments).

 

Leases

 

The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. Control of an underlying asset is conveyed to the Company if the Company obtains the rights to direct the use of and to obtain substantially all of the economic benefits from using the underlying asset. The Company does not separate non-lease components from lease components to which they relate and accounts for the combined lease and non-lease components as a single lease component.

 

 

 13 

 

 

Operating leases are included in our Consolidated Balance Sheet as right-of-use assets, operating lease liabilities – current and operating lease liabilities – long-term. We do not recognize a right-of-use asset and lease liability for leases with a term of 12 months or less. Our current operating leases are for facilities. Our leases may contain renewal options; however, we do not recognize right-of-use assets or lease liabilities for renewal periods unless it is determined that we are reasonably certain of renewing the lease at inception or when a triggering event occurs. Some of our lease agreements may contain rent escalation clauses, rent holidays, capital improvement funding, or other lease concessions.

 

In determining our right-of-use assets and lease liabilities, we apply a discount rate to the minimum lease payments within each lease agreement. ASC 842 requires us to use the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term, an amount equal to the lease payments in a similar economic environment. When we cannot readily determine the discount rate implicit in the lease agreement, we utilize our current borrowing rate on our outstanding line of credit. The Company’s line of credit utilizes market rates to assess an interest rate. Refer to Note G for further discussion.

 

We recognize our minimum rental expense on a straight-line basis based on the fixed components of a lease arrangement. Payments are set on a pre-determined schedule within each lease agreement. We amortize this expense over the term of the lease beginning with the date of the standard adoption for current leases and beginning with the date of initial possession, which is the date we enter the leased space and begin to make improvements in the preparation for its intended use. Variable lease components represent amounts that are not fixed in nature and are not tied to an index or rate and are recognized as incurred. Variable lease components consist primarily of the Company's proportionate share of common area maintenance, utilities, taxes and insurance and are presented as operating expenses in the Company’s statements of operations in the same line item as expense arising from fixed lease payments.

 

Impact of COVID-19 Pandemic

 

The Company’s operations and financial results have also been impacted by the COVID-19 pandemic. Both the health and economic aspects of the COVID-19 pandemic are highly fluid and the future course of each is uncertain. We cannot predict whether the outbreak of COVID-19 will be effectively contained on a sustained basis. Depending on the length and severity of the COVID-19 pandemic, the demand for our products, our customers’ ability to meet payment obligations to the Company, our supply chain and production capabilities, and our workforces’ ability to deliver our products and services could be impacted. Management is actively monitoring the impact of the global situation on the Company’s financial condition, liquidity, operations, suppliers, industry, and workforce. While we expect this disruption to continue to have a material adverse impact on our results of operations, financial condition, cash flows, and liquidity, the Company is unable to reasonably determine the full extent of the impact at this time.

 

Due to travel restrictions, social distancing edicts and overall fear, the hospitality industry, our largest market that generally accounts for a majority of our revenue, has suffered as much as any since the onset of the pandemic. While the industry is trending toward recovery, the situation remains fragile. The effects of supply-chain issues, inflation and labor shortages, and subsequent rising wages, all present some level of pandemic uncertainty for the foreseeable future. STR and Tourism Economics expect leisure travel to pace the recovery while commercial demand, the dominant segment, will remain significantly below pre-pandemic levels until there is a significant increase in the quantity of large group events, as well as the return of business travel [1] When adjusted for inflation, revenue per available room (RevPAR) will likely remain below 2019 levels until at least 2025[2].

 

 

_________________________

[1] O’Conner, Stefani C. “Industry’s recovery heats up-slowly.” Hotelbusiness.com January 2022:8A

[2] O’Conner, Stefani C. “Industry’s recovery heats up-slowly.” Hotelbusiness.com January 2022:14A

 

 

 

 14 

 

 

 

NOTE B – NEW ACCOUNTING PRONOUNCEMENTS

   

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 provides guidance for estimating credit losses on certain types of financial instruments, including trade receivables, by introducing an approach based on expected losses. The expected loss approach will require entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts. ASU 2016-13 also amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. The guidance requires a modified retrospective transition method and early adoption is permitted. In November 2019, FASB issued ASU No. 2019-10, Financial Instruments – Credit Losses, Derivatives and Hedging, and Leases (“ASU 2019-10”), which defers the adoption of ASU 2016-13 for smaller reporting companies until January 1, 2023. The Company will continue to evaluate the impact of ASU 2016-13 on its consolidated financial statements.

 

Management has evaluated other recently issued accounting pronouncements and does not believe any will have a significant impact on our consolidated financial statements and related disclosures.

 

NOTE C – REVENUE

 

The following table presents the Company’s product and recurring revenues disaggregated by industry for the three months ended March 31, 2022. 

                        
   Hospitality   Education   Multiple
Dwelling
Units
   Government   Healthcare   Total 
Product  $1,058,627   $551,381   $69,297   $275,125   $0   $1,954,430 
Recurring   164,434    31,841    0    0    0    196,275 
   $1,223,061   $583,222   $69,297   $275,125   $0   $2,150,705 
    57%    27%    3%    13%    0%    100% 

 

The following table presents the Company’s product and recurring revenues disaggregated by industry for the three months ended March 31, 2021.

 

   Hospitality   Education   Multiple
Dwelling
Units
   Government   Healthcare   Total 
Product  $712,907   $74,103   $172,735   $118,335   $29,784   $1,107,864 
Recurring   162,794    16,426    7,125    0    0    186,345 
   $875,701   $90,529   $179,860   $118,335   $29,784   $1,294,209 
    68%    7%    14%    9%    2%    100% 

 

Sales taxes and other usage-based taxes are excluded from revenues.

 

Remaining performance obligations

 

As of March 31, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was approximately $0.6 million. Except for support services, the Company expects to recognize 100% of the remaining performance obligations over the next six months.

 

Contract assets and liabilities 

        
   March 31,
2022
   December 31,
2021
 
Contract assets  $128,872   $266,014 
Contract liabilities   941,102    941,230 

 

 

 15 

 

 

Contracts are billed in accordance with the terms and conditions, either at periodic intervals or upon substantial completion. This can result in billings occurring subsequent to revenue recognition, resulting in contract assets. Contract assets are presented as current assets in the Condensed Consolidated Balance Sheet.

 

Often, the Company will require customers to pay a deposit upon contract signing that will be applied against work performed or products shipped. In addition, the Company will often invoice the full term of support at the start of the support period. Billings that occur prior to revenue recognition result in contract liabilities. The change in the contract liability balance during the three-month period ended March 31, 2022 is the result of cash payments received and billing in advance of satisfying performance obligations. 

 

Contract costs

 

Costs to complete a turnkey contract primarily relate to the materials cost and direct labor and are recognized proportionately as the performance obligation is satisfied. The Company will defer costs to complete a contract when materials have shipped (and control over the materials has transferred to the customer), but an insignificant amount of rooms have been installed. The Company will recognize any deferred costs in proportion to revenues recognized from the related turnkey contract. The Company does not expect deferred contract costs to be long-lived since a typical turnkey project takes approximately 60 days to complete. Deferred contract costs are generally presented as other current assets in the Condensed Consolidated Balance Sheet.

 

The Company incurs incremental costs to obtain a contract in the form of sales commissions. These costs, whether related to performance obligations that extend beyond 12 months or not, are immaterial and will continue to be recognized in the period incurred within selling, general and administrative expenses.

 

NOTE D – ACCOUNTS RECEIVABLE

 

Components of accounts receivable as of March 31, 2022 and December 31, 2021 are as follows: 

        
   March 31,
2022
   December 31,
2021
 
Accounts receivable  $1,977,914   $1,016,117 
Allowance for doubtful accounts   (12,670)   (5,563)
Accounts receivable, net  $1,965,244   $1,010,554 

 

 

NOTE E – INVENTORIES

 

Components of inventories as of March 31, 2022 and December 31, 2021 are as follows: 

        
   March 31,
2022
   December 31,
2021
 
Product purchased for resale  $1,392,173   $1,269,056 
Reserve for obsolescence   (317,221)   (443,497)
Inventory, net  $1,074,952   $825,559 

 

 

 

 16 

 

 

 

NOTE F – CURRENT ACCRUED LIABILITIES

 

Current accrued liabilities at March 31, 2022 and December 31, 2021 are as follows

        
   March 31,
2022
   December 31,
2021
 
Accrued payroll and payroll taxes  $427,240   $242,131 
Accrued professional   65,222    136,584 
Accrued sales taxes, penalties, and interest   20,166    16,634 
Product warranties   51,418    46,650 
Other accrued liabilities   253,465    276,722 
Total current accrued liabilities  $817,511   $718,721 

   

NOTE G – DEBT

 

Revolving Credit Facility

 

On September 30, 2014, the Company entered into a loan and security agreement (the “Heritage Bank Loan Agreement”), with Heritage Bank of Commerce, a California state chartered bank (“Heritage Bank”), governing a revolving credit facility in a principal amount not to exceed $2,000,000 (subsequently reduced to $1,000,000 on December 13, 2021), (the “Credit Facility”. Availability of borrowings under the Credit Facility is subject to a borrowing base calculation based on the Company’s eligible accounts receivable and eligible inventory each multiplied by an applicable advance rate, with an overall limitation tied to the Company’s eligible accounts receivable. The Credit Facility is secured by all of the Company’s assets. The Heritage Bank Loan Agreement is available for working capital and other general business purposes.

 

The outstanding principal balance of the Credit Facility bears interest at the Prime Rate plus 3.00%, which was 6.50% on March 31, 2022 and 6.25% on December 31, 2021. On October 9, 2014, as part of the Heritage Bank Loan Agreement, Heritage Bank was granted a warrant to purchase 250,000 shares of Telkonet common stock. The warrant had an exercise price of $0.20 and expired October 9, 2021. On November 6, 2019, the Eleventh Amendment to the Credit Facility was executed to extend the maturity date to September 30, 2021, unless earlier accelerated under the terms of the Heritage Bank Loan Agreement, and eliminate the maximum EBITDA loss covenant. The Eleventh Amendment was effective as of September 30, 2019.

 

On September 30, 2021, the Company entered into a twelfth amendment to the Heritage Bank Loan Agreement to extend the revolving maturity date to December 31, 2021, unless earlier accelerated under the terms of the Heritage Bank Loan Agreement. In addition, subject to certain conditions as specified in the Twelfth Amendment, Heritage Bank consented to the VDA Transaction (as described above in Note A – Basis of Presentation and Significant Accounting Policies - Business) between the Company and VDA, and acknowledged and agreed that certain events occurring in connection with the VDA Transaction, including the change of control of the Company resulting from the VDA Transaction, do not constitute Events of Default as defined in the Heritage Bank Loan Agreement.

 

On December 13, 2021, the Company entered into a thirteenth amendment to the Heritage Bank Loan Amendment to extend the revolving maturity date to March 31, 2022, unless earlier accelerated under the terms of the Heritage Bank Loan Agreement. In addition, the Heritage Bank Loan Amendment reduced the credit extension amount to $1,000,000 and reduced unrestricted cash maintained in the Company’s accounts at Bank to be at least $1,000,000.

 

On March 10, 2022, the Company entered into a fourteenth amendment to the Heritage Bank Loan Amendment to extend the revolving maturity date to June 30, 2023, unless earlier accelerated under the terms of the Heritage Bank Loan Agreement.

 

The Heritage Bank Loan Agreement contains covenants that place restrictions on, among other things, the incurrence of debt, granting of liens and sale of assets. The Heritage Bank Loan Agreement also contains financial covenants. As discussed above, the EBITDA loss covenant was eliminated in the eleventh amendment to the Credit Facility. The sole financial covenants are a minimum asset coverage ratio and a minimum unrestricted cash balance of $1 million, both of which are measured at the end of each month. A violation of either of these covenants could result in an event of default under the Heritage Bank Loan Agreement. Upon the occurrence of such an event of default or certain other customary events of defaults, payment of any outstanding amounts under the Credit Facility may be accelerated and Heritage Bank’s commitment to extend credit under the Heritage Bank Loan Agreement may be terminated. The Heritage Bank Loan Agreement contains other representations and warranties, covenants, and other provisions customary to transactions of this nature.

 

 

 17 

 

 

The outstanding balance on the Credit Facility was $436,135 and $403,089 at March 31, 2022 and December 31, 2021 respectively, and the remaining available borrowing capacity was approximately $514,000 and $311,000, respectively. As of March 31, 2022, the Company was in compliance with all financial covenants.

 

Paycheck Protection Program

 

The Company has received two loans under the Paycheck Protection Program (the “PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Keeping American Workers Employed and Paid Act, which is part of the Coronavirus Aid, Relief, and Economic Security Act, enacted on March 27, 2020.

 

On April 17, 2020, the Company entered into an unsecured promissory note for $913,063 (“the First PPP Loan”). In January 2021, the Company applied for forgiveness of the amount due on the First PPP Loan. On February 16, 2021, Heritage Bank confirmed that the First PPP Loan granted to the Company, in the original principal amount of $913,063 plus accrued interest of $7,610 thereon, was forgiven in full.

 

On April 27, 2021, the Company entered into an unsecured promissory note, dated as of April 26, 2021, for a second PPP loan (“the Second PPP Loan” and together with the First PPP Loan, the “PPP Loans”), with Heritage Bank under a second draw of the PPP administered by the SBA and authorized by the Keeping American Workers Employed and Paid Act. In September 2021, the Company applied for forgiveness of the amount due on the Second PPP Loan. On September 15, 2021, Heritage Bank confirmed that the Second PPP Loan granted to the Company, in the original principal amount of $913,063 plus accrued interest of $3,044 thereon, was forgiven in full.

 

The total amount forgiven in 2021 for principal and accrued interest under the PPP Loans was $1,836,780.

 

NOTE H – PREFERRED STOCK

 

Series A

 

The Company has designated 215 shares of preferred stock as Series A Preferred Stock (“Series A”). Each share of Series A is convertible, at the option of the holder thereof, at any time, into shares of the Company’s common stock at a conversion price of $0.363 per share. On November 16, 2009, the Company sold 215 shares of Series A with attached warrants to purchase an aggregate of 1,628,800 shares of the Company’s common stock at $0.33 per share. The Series A shares were sold at a price per share of $5,000 and each Series A share is convertible into approximately 13,774 shares of common stock at a conversion price of $0.363 per share. The Company received $1,075,000 from the sale of the Series A shares. In prior years, 30 of the preferred shares issued on November 16, 2009 were converted to shares of the Company’s common stock. In a prior year, the redemption feature available to the Series A holders expired. On March 31, 2022, four Series A4 shares were repurchased per the terms of a separation agreement with Jason L. Tienor, former President and Chief Executive Officer, who will receive reimbursement for the shares.

 

Series B

 

The Company has designated 567 shares of preferred stock as Series B Preferred Stock (“Series B”). Each share of Series B is convertible, at the option of the holder thereof, at any time, into shares of the Company’s common stock at a conversion price of $0.13 per share. On August 4, 2010, the Company sold 267 shares of Series B with attached warrants to purchase an aggregate of 5,134,626 shares of the Company’s common stock at $0.13 per share. The Series B shares were sold at a price per share of $5,000 and each Series B share was convertible into approximately 38,461 shares of common stock at a conversion price of $0.13 per share. The Company received $1,335,000 from the sale of the Series B shares on August 4, 2010.  On April 8, 2011, the Company sold 271 additional shares of Series B with attached warrants to purchase an aggregate of 5,211,542 shares of the Company’s common stock at $0.13 per share. The Series B shares were sold at a price per share of $5,000 and each Series B share was convertible into approximately 38,461 shares of common stock at a conversion price of $0.13 per share. The Company received $1,355,000 from the sale of the Series B shares on April 8, 2011. In prior years, 486 of the preferred shares issued on August 4, 2010 and April 8, 2011 were converted to shares of the Company’s common stock. In a prior year, the redemption feature available to the Series B holders expired.

 

Preferred stock carries certain preference rights as detailed in the Company’s Amended Articles of Incorporation related to both the payment of dividends and as to payments upon liquidation in preference to any other class or series of capital stock of the Company. As of March 31, 2022, the liquidation preference of the preferred stock is based on the following order: first, Series B with a preference value of $502,740, which includes cumulative accrued unpaid dividends of $242,740, and second, Series A with a preference value of $1,800,887, which includes cumulative accrued unpaid dividends of $895,887.

 

 

 18 

 

 

  

NOTE I – STOCK OPTIONS AND WARRANTS

 

Employee Stock Options

 

The Company maintains an equity incentive plan (the “2020 Plan”). The 2020 Plan was established in 2020 as an incentive plan for officers, employees, non-employee directors, prospective employees and other key persons. The 2020 Plan replaced the 2010 Amended and Restated Stock Option and Incentive Plan, as amended (the “2010 Plan”), which expired on November 17, 2020. The 2020 Plan is administered by the Board of Directors or the compensation committee, which is comprised of not less than two non-employee directors who are independent. A total of 10,000,000 shares of stock were reserved and available for issuance under the 2020 Plan. The exercise price per share for the stock covered by a stock option granted shall be determined by the administrator at the time of grant but shall not be less than 100 percent of the fair market value on the date of grant. The term of each stock option shall be fixed by the administrator, but no stock option shall be exercisable more than ten years after the date the stock option is granted. As of March 31, 2022, there were approximately 10,000,000 shares remaining for issuance under the 2020 Plan.

 

It is anticipated that providing such persons with a direct stake in the Company’s welfare will assure a better alignment of their interests with those of the Company and its stockholders.

 

The following table summarizes the changes in options outstanding and the related prices for the shares of the Company’s common stock issued to employees of the Company under the 2010 Plan as of March 31, 2022. No options have been issued under the 2021 Plan.  

                         
   Options Outstanding   Options Exercisable 
Exercise Prices  Number
Outstanding
   Weighted Average
Remaining
Contractual Life
(Years)
   Weighted Average
Exercise Price
   Number
Exercisable
   Weighted Average
Exercise Price
 
$0.01 - $0.15   2,000,000    4.76   $0.14    2,000,000   $0.14 
$0.16 - $0.30   1,323,552    1.49    0.18    1,310,573    0.18 
    3,323,552    3.46   $0.16    3,310,573   $0.16 

 

Transactions involving stock options issued to employees are summarized as follows:  

        
   Number of
Shares
   Weighted Average Exercise
Price Per Share
 
Outstanding at January 1, 2021   3,349,793   $0.16 
Granted        
Exercised        
Cancelled or expired        
Outstanding at December 31, 2021   3,349,793   $0.16 
Granted        
Exercised        
Cancelled or expired   (26,241)   0.17 
Outstanding at March 31, 2022   3,323,552   $0.16 

 

 

 20 

 

 

The expected life of awards granted represents the period of time that they are expected to be outstanding. The Company determines the expected life based on historical experience with similar awards, giving consideration to the contractual terms, vesting schedules, exercise patterns and pre-vesting and post-vesting forfeitures. The Company estimates the volatility of the Company’s common stock based on the calculated historical volatility of the Company’s common stock using the share price data for the trailing period equal to the expected term prior to the date of the award. The Company bases the risk-free interest rate used in the Black Scholes option valuation model on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term equal to the expected life of the award. The Company has not paid any cash dividends on the Company’s common stock and does not anticipate paying any cash dividends in the foreseeable future. Consequently, the Company uses an expected dividend yield of zero in the Black-Scholes option valuation model. The Company uses historical data to estimate pre-vesting option forfeitures and records share-based compensation for those awards that are expected to vest. In accordance with ASC 718-10, the Company calculates share-based compensation for changes to the estimate of expected equity award forfeitures based on actual forfeiture experience.

 

The total estimated fair value of the options granted during both the quarters ended March 31, 2022 and 2021 was $0. The total fair value of underlying shares related to options that vested during the quarters ended March 31, 2022 and 2021 was $2,015 and $3,385, respectively. The aggregate intrinsic value of the vested options was zero as of March 31, 2022 and 2021. During the quarters ended March 31, 2022 and 2021, no options were granted, exercised, cancelled or expired. Total stock-based compensation expense in connection with options granted to employees recognized in the consolidated statements of operations for both the quarters ended March 31, 2022 and 2021 was $1,815.

 

Warrants

 

The following table summarizes the changes in warrants outstanding and the related exercise price for the 250,000 warrants issued to Heritage Bank in connection with the Credit Facility (see Note G) and the 105,380,666 warrants issued to VDA in connection with the VDA Transaction (see Note A).

 

Transactions involving warrants are summarized as follows:  

        
   Number of
Shares
   Weighted Average Exercise
Price Per Share
 
Outstanding at January 1, 2021   250,000   $0.16 
Issued        
Exercised        
Cancelled or expired   (250,000)   (0.16)
Outstanding at December 31, 2021        
Issued   105,380,666    0.06 
Exercised        
Cancelled or expired        
Outstanding at March 31, 2022   105,380,666   $0.06 

   

NOTE J – STOCK ISSUANCE TO NON-EMPLOYEE DIRECTORS

 

During the quarters ended March 31, 2022 and 2021, the Company issued common stock valued at $0 and $18,000, and paid cash consideration of $236,333 and $15,000, respectively to the Company’s non-employee directors as compensation for their attendance and participation in the Company’s Board of Director and committee meetings. The amount payable to directors at March 31, 2022 and 2021 was $6,667 and $127,000, respectively.

  

 

 21 

 

 

NOTE K – COMMITMENTS AND CONTINGENCIES

 

Office Leases Obligations

 

In October 2013, the Company entered into a lease agreement for 6,362 square feet of commercial office space in Waukesha, Wisconsin for its corporate headquarters. The Waukesha lease would have expired in April 2021, but was subsequently amended and extended through April 2026. On April 7, 2017 the Company executed an amendment to its existing lease in Waukesha, Wisconsin to expand another 3,982 square feet, bringing the total leased space to 10,344 square feet. In addition, the lease term was extended from May 1, 2021 to April 30, 2026. The commencement date for this amendment was July 15, 2017.

 

In May 2017, the Company entered into a lease agreement for 5,838 square feet of floor space in Waukesha, Wisconsin for its inventory warehousing operations. This lease expires in May 2024.

 

In November 2021, the Company entered into a lease agreement for 425 square feet of commercial office space in Gaithersburg, Maryland. This lease expires on November 30, 2022.

 

The components of lease expense for the 3 months ended March 31 are as follows:  

        
Operating lease expense:  2022   2021 
Operating lease cost - fixed  $49,024   $57,387 
Variable lease cost   31,912    30,137 
Total operating lease cost  $80,936   $87,524 

 

Other information related to leases as of March 31 is as follows:  

        
   2022   2021 
Operating lease liability - current  $145,409   $242,299 
Operating lease liability - long-term  $470,591   $592,341 
Operating cash outflows from operating leases  $38,843   $57,658 
           
Weighted-average remaining lease term of operating leases   3.9 years     4.8 years 
Weighted-average discount rate of operating leases   8.5%    8.5% 

 

Future annual minimum operating lease payments as of March 31, 2022 were as follows:  

     
2022  $143,077 
2023   193,169 
2024   172,425 
2025   158,510 
2026 and thereafter   53,183 
Total minimum lease payments   720,364 
Less imputed interest   (104,364)
Total  $616,000 

 

Rental expenses charged to operations for the 3 months ended March 31, 2022 and 2021 were $80,936 and $87,524, respectively.

 

 

 22 

 

 

Employment and Consulting Agreements

 

The Company has employment agreements with certain of its key employees which include non-disclosure and confidentiality provisions for protection of the Company’s proprietary information.

 

Under the terms of a Consulting Agreement, Piercarlo Gramaglia will serve as Chief Executive Officer of the Company for a term of eighteen (18) months, unless earlier terminated pursuant to the terms of the Consulting Agreement. In exchange for his service as Chief Executive Officer, the Company will pay Mr. Gramaglia an annual fee of $30,000 and will pay his reasonable expenses associated with the performance of his duties as Chief Executive Officer.

 

Jeffrey J. Sobieski, Chief Technology Officer, is employed pursuant to an employment agreement with us effective January 7, 2022. Mr. Sobieski’s employment agreement has an initial term of one (1) year, which will automatically renew for a period of an additional twelve (12) months, and provides for a base salary of $211,625 per year and bonuses and benefits based upon the Company’s internal policies and participation in the Company’s incentive and benefit plans. Per the agreement, Mr. Sobieski is eligible to receive a bonus, not to exceed 15% of his base salary, should predetermined objectives be met.

 

Richard E. Mushrush, Chief Financial Officer, is employed pursuant to an employment agreement with us effective January 7, 2022. Mr. Mushrush’s employment agreement has an initial term of one (1) year, which will automatically renew for a period of an additional twelve (12) months, and provides for a base salary of $122,000 per year and bonuses and benefits based upon the Company’s internal policies and participation in the Company’s incentive and benefit plans. Per the agreement, Mr. Mushrush is eligible to receive a bonus, not to exceed 20% of his base salary, should predetermined objectives be met. 

 

Under the terms of the severance agreement with Mr. Jason L. Tienor signed March 10, 2022 and filed with Form 8-K of that date, severance costs associated with this agreement of $222,800 have been accrued in the quarter ending March 31, 2022.

 

In addition to the foregoing, stock options are periodically granted to employees under the Company’s 2020 equity incentive plan at the discretion of the Compensation Committee of the Board of Directors. Executives of the Company are eligible to receive stock option grants, based upon individual performance and the performance of the Company as a whole.

 

Litigation

 

The Company is subject to legal proceedings and claims which arise in the ordinary course of its business. Although occasional adverse decisions or settlements may occur, other than the Sipco Lawsuit discussed below and which has been terminated, the Company believes that the final disposition of such matters should not have a material adverse effect on its financial position, results of operations or liquidity.

 

Sipco Litigation and License Agreement

 

The company continues to fulfill its obligations of the Wireless Network Patent License Agreement (the “License Agreement”) with SIPCO, LLC (“Sipco”) and IPCO, LLC dba IntusIQ (collectively, the “Licensors”) in order to settle the Sipco Lawsuit, without the expense of costly litigation.

 

The minimum payments required under the License Agreement have been accrued for on the Company’s Consolidated Balance Sheet in accordance with GAAP, which specifies that when a liability is probable and the amount can be reasonably estimated, said liability should be recorded in the current reporting period. Per the License Agreement, the contractual minimum payments began on January 1, 2022 and continue until December 31, 2024, thus satisfying both criteria of probable and reasonably estimable. Accordingly, a long-term liability was recorded representing the sum of those contractual minimums. As of March 31, 2022, the Company had a current liability of approximately $140,000, which $41,940 is included in accounts payable and $133,060 in other accrued liabilities (See Note F – Current Accrued Liabilities for further breakdown of accrued liabilities), along with a non-current liability of $325,000 included in accrued royalties – long-term recorded on its Consolidated Balance Sheet.

 

Indemnification Agreements

 

On March 31, 2010, the Company entered into Indemnification Agreements with executives Jason L. Tienor, then President and Chief Executive Officer, and Jeffrey J. Sobieski, then Chief Operating Officer. On April 24, 2012, the Company entered into an Indemnification Agreement with director Tim S. Ledwick. On January 1, 2017, the Company entered into an Indemnification Agreement with Chief Financial Officer Richard E. Mushrush.

 

 

 23 

 

 

The Indemnification Agreements provide that the Company will indemnify the Company's officers and directors, to the fullest extent permitted by law, relating to, resulting from or arising out of any threatened, pending or completed action, suit or proceeding, or any inquiry or investigation by reason of the fact that such officer or director (i) is or was a director, officer, employee or agent of the Company or (ii) is or was serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. In addition, the Indemnification Agreements provide that the Company will make an advance payment of expenses to any officer or director who has entered into an Indemnification Agreement, in order to cover a claim relating to any fact or occurrence arising from or relating to events or occurrences specified in this paragraph, subject to receipt of an undertaking by or on behalf of such officer or director to repay such amount if it shall ultimately be determined that he is not entitled to be indemnified by the Company as authorized under the Indemnification Agreement.

 

Sales Tax

 

The following table sets forth the change in the sales tax accrual as of March 31, 2022 and December 31, 2021: 

        
   March 31,
2022
   December 31,
2021
 
Balance, beginning of year  $16,634   $31,396 
Sales tax collected   39,513    85,589 
Provisions (reversals)   2,646    (7,685)
Payments   (38,627)   (92,666)
Balance, end of period  $20,166   $16,634 

 

NOTE L – BUSINESS CONCENTRATION

 

For the three months ended March 31, 2022, three customers, each representing over 10% of total net revenues, accounted for approximately 50% of total net revenues. For the three months ended March 31, 2021, two customers, accounted for approximately 25% of total net revenues.

 

As of March 31, 2022, there were three customers, each representing over 10% of the Company’s net accounts receivable, accounting for 52% of the Company’s net accounts receivable. As of December 31, 2021, there were five customers, each representing over 10% of the Company’s net accounts receivable, accounting for 64% of the Company’s net accounts receivable.

 

For the three months ended March 31, 2022, purchases from two suppliers, accounted for approximately $892,000, or 95%, of total purchases and approximately $62,000, or 63%, of total purchases for the three months ended March 31, 2021. The amount due to one supplier, net of deposits paid, was approximately $694,000 and $651,000 as of March 31, 2022 and December 31, 2021, respectively.

 

 

 24 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the accompanying condensed consolidated financial statements and related notes thereto for the three months ended March 31, 2022, as well as the Company’s consolidated financial statements and related notes thereto and management’s discussion and analysis of financial condition and results of operations in the Company’s Form 10-K for the year ended December 31, 2021, filed with the US. Securities and Exchange Commission (the “SEC”) on March 31, 2022.

 

Business

 

The Company’s direct sales effort targets the hospitality, education, commercial, utility and government/military markets. The Company is focusing its sales efforts in areas with available public funding and incentives, such as rebate programs offered by utilities for efficiency upgrades. Through the Company’s proprietary platforms, technology and partnerships with energy efficiency providers, the Company’s management intends to position the Company as a leading provider of energy management solutions.

 

Forward-Looking Statements

 

In accordance with the Private Securities Litigation Reform Act of 1995, the Company can obtain a “safe-harbor” for forward-looking statements by identifying those statements and by accompanying those statements with cautionary statements which identify factors that could cause actual results to differ materially from those in the forward-looking statements. Accordingly, the following “Management’s Discussion and Analysis of Financial Condition and Results of Operations” may contain certain forward-looking statements regarding strategic growth initiatives, growth opportunities and management’s expectations regarding orders and financial results for the remainder of 2022 and future periods. These forward-looking statements are based on current expectations and current assumptions which management believes are reasonable. However, these statements involve risks and uncertainties that could cause actual results to differ materially from any future results encompassed within the forward-looking statements.  Factors that could cause or contribute to such differences include those risks as described in the Company’s filings with the SEC, including the current reports on Form 8-K, which factors are incorporated herein by reference. The Company expressly disclaims a duty to provide updates to forward-looking statements, whether as a result of new information, future events or other occurrences.

 

Critical Accounting Policies and Estimates and New Accounting Pronouncements

 

Please refer to Notes A & B contained in Part I.

 

Revenues

 

The table below outlines product versus recurring revenues for comparable periods:

 

   Three Months Ended 
   March 31, 2022   March 31, 2021   Variance 
                         
Product  $1,954,430    91%   $1,107,864    86%   $846,566    76% 
Recurring   196,275    9%    186,345    14%    9,930    5% 
Total  $2,150,705    100%   $1,294,209    100%   $856,496    66% 

 

 

 25 

 

 

Product Revenue

 

Product revenue principally arises from the sale and installation of energy management platforms. The suite of products consists of thermostats, sensors, controllers, wireless networking products, switches, outlets and a control platform.

 

For the three months ended March 31, 2022, product revenues increased by 76% or $0.85 million when compared to the prior year. Hospitality revenues increased 40% to $1.06 million, government revenues increased 132% to $0.28 million, education revenues increased 644% to $0.55 million while MDU revenues decreased 60% to $0.07 million and healthcare revenues decreased 100% to $0.00 million. Product revenues derived from value-added resellers and distribution partners were $1.42 million for the three months ended March 31, 2022, an increase of 55% compared to the prior year period. The increase was primarily driven by three customers, partially offset by non-repeatable revenues in 2022 from four customers. For the three months ended March 31, 2022, international revenues decreased 45% to $0.14 million when compared to the prior year period. The decrease in international revenues was primarily driven by non-repeatable revenues in 2022 from two customers. 

 

Backlogs were approximately $3.2 million and $2.6 million at March 31, 2022 and 2021, respectively. Beginning in the third quarter of 2021, global supply chain disruptions have created delays in our order fulfillment. These disruptions are ongoing and order cancellations could result if these issues persist.

 

Recurring Revenue

 

Recurring revenue is attributed to our call center support services. The Company recognizes revenue ratably over the service period for monthly support revenues and defers revenue for annual support services over the term of the service period. Recurring revenue consists of Telkonet’s service and support programs for its energy management platforms. For the three months ended March 31, 2022, recurring revenue increased by 5% when compared to the prior year period. The increase was related to increased unit sales of call center support services. 

 

Cost of Sales

 

The table below outlines product versus recurring cost of sales, along with respective amounts of those costs as a percentage of revenue for the comparable periods:

 

   Three Months Ended 
   March 31, 2022   March 31, 2021   Variance 
                         
Product  $1,132,900    58%   $577,814    52%   $555,087    96% 
Recurring   31,770    16%    10,900    6%    20,870    191% 
Total  $1,164,670    54%   $588,714    45%   $575,957    98% 

  

Costs of Product Revenue

 

Costs of product revenue include materials and installation labor related to Telkonet’s platform technologies. For the three months ended March 31, 2022, product costs increased $0.56 million compared to the prior year period based upon greater revenues. The variance was primarily attributable to increases in material costs of $0.47 million, inclusive of product surcharges of $0.24 million resulting from global chip shortages, supply chain challenges and inflationary pressures, logistical expenses of $0.08 million, inclusive of import tariffs, warranty expense of $0.02 million and the use of installation subcontractors of $0.13 million, partially offset by a decrease in inventory adjustments of $0.15 million. Material costs as a percentage of product revenues were 40%, an increase of 7%, compared to the prior year period.

  

Costs of Recurring Revenue

 

Recurring revenue costs are comprised primarily of call center support labor. For the three months ended March 31, 2022, recurring revenue costs increased by 191% when compared to the prior year period. The variance was primarily due to increases in call center staffing. 

  

 

 26 

 

 

Gross Profit 

 

The table below outlines product versus recurring gross profit, along with respective actual gross profit percentages for the comparable periods:

 

   Three Months Ended 
   March 31, 2022   March 31, 2021   Variance 
                         
Product  $821,530    42%   $530,050    48%   $291,479    55% 
Recurring   164,505    84%    175,445    94%    (10,940)   -6% 
Total  $986,035    46%   $705,495    55%   $280,539    40% 

  

Gross Profit on Product Revenue

 

Gross profit on product revenues for the three months ended March 31, 2022 increased by 55%, or $0.29 million, when compared to the prior period. The variance was primarily attributable to an increase in revenues of $0.56 million and a decrease in inventory adjustments of $0.15 million, partially offset by increases in material costs of $0.47 million, inclusive of product surcharges of $0.24 million resulting from global chip shortages, supply chain challenges and inflationary pressures, logistical expenses of $0.08 million, inclusive of import tariffs, warranty expense of $0.02 million and the use of installation subcontractors of $0.13 million. Material costs as a percentage of product revenues were 40%, an increase of 7%, compared to the prior year period. For the three months ended March 31, 2022, the actual gross profit percentage decreased by 9% to 46% compared to the prior year period. Tariffs imposed on Chinese imports resulted in an adverse impact of approximately 5% on the actual gross profit percentage for the three months ended March 31, 2022, compared to approximately 3% for the prior year period. 

  

Gross Profit on Recurring Revenue

 

Gross profit on recurring revenue for the three months ended March 31, 2022 decreased 6% when compared to the prior year period.

  

Operating Expenses

 

The tables below outline operating expenses for the comparable periods, along with percentage change:

 

   Three Months Ended March 31, 
   2022   2021   Variance 
                     
Total  $1,491,506   $1,535,791   $(44,285)   -3% 

 

The Company’s operating expenses are comprised of research and development, selling, general and administrative expenses and depreciation and amortization expense. During the three months ended March 31, 2022, operating expense decreased by 3% when compared to the prior year period.

 

Research and Development

 

   Three Months Ended March 31, 
   2022   2021   Variance 
                     
Total  $269,240   $311,448   $(42,208)   (14)%

 

Research and development costs are related to both present and future product development and integration and are expensed in the period incurred. During the three months ended March 31, 2022, research and development costs decreased 14% when compared to the prior year period. The variance is primarily attributable to decreases in payroll of $0.04 million and certification expenses of $0.01 million partially offset by an increase in third-party consultant expenses of $0.01 million.

 

 

 27 

 

 

Selling, General and Administrative Expenses

 

   Three Months Ended March 31, 
   2022   2021   Variance 
                     
Total  $1,212,813   $1,211,103   $1,710    0% 

 

During the three months ended March 31, 2022, selling, general and administrative expenses remained unchanged compared to the prior year period. 

 

Operating Loss and Net Income (Loss)

 

During the three months ended March 31, 2022, the Company had an operating loss of ($0.52) million, compared to an operating loss of ($0.83) million during the prior year period. The improvement was primarily due to incremental gross profit from additional revenue and a (3%) decrease in operating expenses.

 

During the three months ended March 31, 2022, the Company had net loss of ($0.52) million compared to net income of $0.08 million for the prior year period. The decrease in profitability was primarily due to the non-recurrence of a $0.92 million non-cash gain on debt extinguishment in connection with the full forgiveness of the First PPP Loan in the prior year period. This was partially offset by the impact of increased revenues and a decrease in expenses as discussed above. 

 

Non-GAAP Financial Measures

 

Management believes that certain non-GAAP financial measures may be useful to investors in certain instances to provide additional meaningful comparisons between current results and results in prior operating periods. Adjusted earnings before interest, taxes, depreciation, amortization and stock-based compensation (“Adjusted EBITDA”) is a metric used by management and frequently used by the financial community. Adjusted EBITDA provides insight into an organization’s operating trends and facilitates comparisons between peer companies, since interest, taxes, depreciation, amortization and stock-based compensation can differ greatly between organizations as a result of differing capital structures and tax strategies. Adjusted EBITDA is one of the measures used for determining our debt covenant compliance. Adjusted EBITDA excludes certain items that are unusual in nature or not comparable from period to period. While management believes that non-GAAP measurements are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results. Adjusted EBITDA is not, and should not be considered, an alternative to net income (loss), operating income (loss), or any other measure for determining operating performance or liquidity, as determined under accounting principles generally accepted in the United States (GAAP). In assessing the overall health of its business for the three months ended March 31, 2022 and 2021, the Company believes it appropriate to exclude stock-based compensation given the variety of equity awards used by companies, varying methodologies for determining stock-based compensation and the assumptions and estimates involved in those determinations, the exclusion of non-cash stock-based compensation enhances the ability of management and investors to understand the impact of non-cash stock-based compensation on our operating results. Further, the Company believes that excluding stock-based compensation expense allows for a more transparent comparison of its financial results to the previous year.

 

RECONCILIATION OF NET INCOME (LOSS)

TO ADJUSTED EBITDA

FOR THE THREE MONTHS ENDED MARCH 31,

 

    2022     2021  
Net income (loss)   $ (517,828 )   $ 82,739  
Gain on debt extinguishment           (920,673 )
Interest expense, net     12,357       7,873  
Income tax (benefit) provision           (235 )
Depreciation and amortization     9,453       13,240  
EBITDA     (496,018 )     (817,056 )
Adjustments:                
Stock-based compensation     1,815       1,815  
Adjusted EBITDA   $ (494,203 )   $ (815,241 )

 

 

 

 28 

 

 

Liquidity and Capital Resources

 

For the three-month period ended March 31, 2022, the Company reported a net loss of ($517,828) and had cash used in operating activities of ($1,515,209) and ended the period with an accumulated deficit of ($129,186,004) and total current assets in excess of current liabilities of $5,668,680. At March 31, 2022, the Company had $5,878,897 of cash and approximately $514,000 of availability on its Credit Facility.

 

Since inception through March 31, 2022, we have incurred cumulative losses of ($129,186,004) and have never generated enough cash through operations to support our business. The Company has made significant investments in the engineering, development and marketing of its intelligent automation platforms, including but not limited to, hardware and software enhancements, support services and applications. The funding for these development efforts has contributed to, and continues to contribute to, the ongoing operating losses and use of cash.

 

The Company took and continues to take a number of actions to preserve cash. These actions ranged from suspending the use of engineering consultants, cancelling all non-essential travel, not filling certain vacancies and for certain periods, furloughing certain employees and pay cuts for certain other employees and suspension of the Company’s 401(k) match. Receipt of PPP monies helped the company reinstate some of cuts made. With the receipt of the First PPP Loan on April 17, 2020 (discussed below), the Company was able to lift some of these mandates in order to return necessary personnel for the Company’s ongoing operations.

 

In addition, on January 12, 2022, the Company closed on the VDA Transaction (see Note A), resulting in additional working capital of $5,000,000.

 

Loans under PPP

 

In addition to the actions noted above, on April 21, 2020, the Company entered into an unsecured promissory note, dated April 17, 2020, with Heritage Bank for a $913,063 loan under the PPP (“the First PPP Loan”). In January 2021, the Company applied for forgiveness of the amount due on the First PPP Loan. On February 16, 2021, the outstanding principal and interest accrued on the First PPP Loan was fully forgiven.

 

On April 27, 2021, the Company entered into a second unsecured promissory note, dated as of April 26, 2021, for a second PPP loan (“the Second PPP Loan” and, together with the First PPP Loan, the “PPP Loans”), with Heritage Bank under a second draw of the PPP administered by the SBA and authorized by the Keeping American Workers Employed and Paid Act. In September 2021, the Company applied for forgiveness of the amount due on the Second PPP Loan. On September 15, 2021, Heritage Bank confirmed that the Second PPP Loan granted to the Company, in the original principal amount of $913,063 plus accrued interest of $3,044 thereon, was forgiven in full.

  

Working Capital

 

Working capital (current assets in excess of current liabilities) from operations increased by $4,459,318 during the three months ended March 31, 2022 from working capital of $1,209,361 at December 31, 2021 to a working capital of $ 5,668,679 at March 31, 2022. The increase in working capital was primarily due to the injection of funds from the $5 million common shares purchase.

  

Revolving Credit Facility

 

On September 30, 2014, the Company entered into the Heritage Bank Loan Agreement, with Heritage Bank, governing a revolving credit facility in a principal amount not to exceed $2,000,000. Availability of borrowings under the Credit Facility is subject to a borrowing base calculation based on the Company’s eligible accounts receivable and eligible inventory each multiplied by an applicable advance rate, with an overall limitation tied to the Company’s eligible accounts receivable. The Heritage Bank Loan Agreement is available for working capital and other general business purposes.

 

The outstanding principal balance of the Credit Facility bears interest at the Prime Rate plus 3.00%, which was 6.25% at both March 31, 2022 and December 31, 2021. On October 9, 2014, as part of the Heritage Bank Loan Agreement, Heritage Bank was granted a warrant to purchase 250,000 shares of Telkonet common stock (which expired, on October 9, 2021). On November 6, 2019, the eleventh amendment to the Credit Facility was executed to extend the maturity date to September 30, 2021, unless earlier accelerated under the terms of the Heritage Bank Loan Agreement, and eliminate the maximum EBITDA loss covenant.  The eleventh amendment was effective as of September 30, 2019.

 

 

 29 

 

 

On September 30, 2021, the Company entered into a twelfth amendment to the Heritage Bank Loan Agreement to extend the revolving maturity date to December 31, 2021, unless earlier accelerated under the terms of the Heritage Bank Loan Agreement. In addition, subject to certain conditions as specified in the Twelfth Amendment, Heritage Bank consented to the VDA Transaction (as described above under the “Business and Basis of Presentation” section in Note A – Basis of Presentation and Significant Accounting Policies) between the Company and VDA, and acknowledged and agreed that certain events occurring in connection with the Transaction, including the change of control of the Company resulting from the Transaction, do not constitute Events of Default as defined in the Loan Agreement.

 

On December 13, 2021, the Company entered into a thirteenth amendment to the Heritage Bank Loan Amendment to extend the revolving maturity date to March 31, 2022, unless earlier accelerated under the terms of the Heritage Bank Loan Agreement. In addition, the Heritage Bank Loan Amendment reduced the credit extension amount to $1,000,000 and reduced unrestricted cash maintained in the Company’s accounts at Bank to be at least $1,000,000.

 

On March 10, 2022, the Company entered into a fourteenth amendment to the Heritage Bank Loan Amendment to extend the revolving maturity date to June 30, 2023, unless earlier accelerated under the terms of the Heritage Bank Loan Agreement.

 

The Heritage Bank Loan Agreement contains covenants that place restrictions on, among other things, the incurrence of debt, granting of liens and sale of assets. The Heritage Bank Loan Agreement also contains financial covenants. As discussed above, the EBITDA loss covenant was eliminated in the eleventh amendment to the Credit Facility. The sole financial covenants are a minimum asset coverage ratio and a minimum unrestricted cash balance of $2 million (since reduced to $1 million), both of which are measured at the end of each month. A violation of either of these covenants could result in an event of default under the Heritage Bank Loan Agreement. Upon the occurrence of such an event of default or certain other customary events of defaults, payment of any outstanding amounts under the Credit Facility may be accelerated and Heritage Bank’s commitment to extend credit under the Heritage Bank Loan Agreement may be terminated. The Heritage Bank Loan Agreement contains other representations and warranties, covenants, and other provisions customary to transactions of this nature.

 

The outstanding balance on the Credit Facility was $436,136 and $403,089 at March 31, 2022 and December 31, 2021 and the remaining available borrowing capacity was approximately $514,000 and $460,000, respectively. As of March 31, 2022, the Company was in compliance with all financial covenants.

 

Cash Flow Analysis

 

Cash used in operations was $1,515,209 and $653,953, during the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, our primary capital needs included costs incurred to increase energy management sales, inventory procurement and managing current liabilities. The working capital changes during the three months ended March 31, 2022 were primarily a result of the $5 million received as a result of the VDA Transaction, a $955,000 increase in accounts receivable, $249,000 increase in inventories, a $242,000 reduction in accounts payable, partially offset by a $398,000 decrease in prepaid items, a $299,000 increase in accrued liabilities and $33,000 from the line of credit. Accounts receivable balances fluctuate based on the negotiated billing terms with customers and collections. We purchase inventory based on forecasts and orders, and when those forecasts and orders change, the amount of inventory may also fluctuate. Accounts payable balances fluctuate with changes in inventory levels, volume of inventory purchases, and negotiated supplier and vendor terms.

 

Off-Balance Sheet Arrangements

 

The Company has no material off-balance sheet arrangements.

  

Acquisition or Disposition of Property and Equipment

 

The Company does not anticipate significant purchases of property or equipment during the next twelve months.

 

Item 3. Quantitative and qualitative disclosures about market risk

 

Not applicable

 

 

 30 

 

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures 

 

We maintain disclosure controls and procedures that are designed to ensure that material information required to be disclosed in our periodic reports filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure. The Company’s Chief Executive Officer and Chief Financial Officer each evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2022. Based on these evaluations, the Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures required by paragraph (b) of Rule 13a-15 and 15d-15 were not effective as of March 31, 2022 as a result of the material weaknesses discussed below.

 

Management’s Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act. The Company’s internal control over financial reporting is designed to provide reasonable assurances regarding the reliability of financial reporting and the preparation of the financial statements of the Company in accordance with U.S. generally accepted accounting principles, or GAAP. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate.

 

With the participation of our Chief Executive Officer, our management conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2021 based on the framework in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on our evaluation and the material weaknesses described below, management concluded that the Company did not maintain effective internal control over financial reporting as of December 31, 2021 based on the COSO framework criteria.

 

Management did not properly design or maintain effective controls over certain aspects of the control environment and monitoring components of COSO. We did not have a sufficient complement of accounting and financial personnel with an appropriate level of knowledge to address technical accounting and financial reporting matters in accordance with GAAP and the Company’s overall financial reporting requirements. We also lack sufficient information technology resources to address our IT general control environment requirements. The failures within the control environment and monitoring components contributed to the following control activity level material weaknesses:

 

·Revenues – We did not properly design or maintain effective controls over the recording of revenue recognition for contracts whose performance obligations are fulfilled over time.
   
·Financial Statement Close and Reporting – We did not properly design or maintain effective controls over the period end financial close and reporting process. Specifically, we lacked control over the review of account reconciliations, journal entries, identification of related party transactions, and reporting of our financial results and disclosures.
   
·Information Technology – We did not properly design or maintain effective controls to prevent unauthorized access to certain systems, programs and data, and provide for periodic review and monitoring of access and changes in programs, including review of security logs and analysis of segregation of duties conflicts.
   
·Segregation of Duties – We did not maintain adequate segregation of duties within the Company’s business processes, financial applications, and IT systems. Specifically, we did not have appropriate controls in place to adequately assess the segregation of job responsibilities and system user access for initiating, authorizing, and recording transactions.

 

These control deficiencies could result in a misstatement of account balances resulting in a more than remote likelihood that a material misstatement to our financial statements may not be prevented or detected on a timely basis. Accordingly, we have determined that these control deficiencies as described above constitute material weaknesses.

 

 

 31 

 

 

As we continue to evaluate and work to improve our internal controls over financial reporting, our senior management may determine to take additional measures to address deficiencies or modify the remediation efforts. Until the remediation efforts that our senior management may identify as necessary, are completed, tested and determined effective, the material weaknesses described above will continue to exist. At present, the Company does not expect to hire additional personnel to remediate these control deficiencies in the near future.

 

In light of these material weaknesses, we performed additional analyses and procedures in order to conclude that our consolidated financial statements as of and for the year ended December 31, 2021, included in the Annual Report on Form 10-K were fairly stated in accordance with U.S. GAAP. Notwithstanding the identified material weaknesses, our management has concluded that the audited financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2021 and the unaudited condensed consolidated financial statements included in this quarterly filing fairly represent, in all material respects, our financial position, results of operations, cash flows, and changes in stockholders’ equity as of and for the periods presented in accordance with U.S. GAAP.

 

Under applicable Securities Law, the Company is not required to obtain an attestation report from the Company's independent registered public accounting firm regarding internal control over financial reporting, and accordingly, such an attestation has not been obtained or included in the Annual Report on Form 10-K for the year ended December 31, 2021.

 

Changes in Internal Controls

 

Other than the material weaknesses discussed above, during the quarter ended March 31, 2022, there have been no changes in our internal controls over financial reporting that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

 

 

 32 

 

 

PART II. OTHER INFORMATION

  

Item 1. Legal Proceedings.

 

The Company is subject to legal proceedings and claims which arise in the ordinary course of its business.  Although occasional adverse decisions or settlements may occur, other than the Sipco Lawsuit, which is discussed in Note L – Commitments and Contingencies in the Notes to the Condensed Consolidated Financial Statements under Item 1 of Part I of this Form 10-Q and was terminated in the fourth quarter of 2020. The Company believes that the final disposition of such matters should not have a material adverse effect on its financial position, results of operations or liquidity.

   

Item 1A. Risk Factors.

 

There were no material changes during the quarter to the Risk Factors disclosed in Item 1A – “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2021.

 

Item 2. Unrestricted sales of equity securities and use of proceeds

 

None

  

Item 3. Defaults upon senior securities

 

None

  

Item 4. Mine safety disclosures

 

None

  

Item 5. Other information

 

None

  

Item 6. Exhibits.

  

Exhibit Number   Description Of Document
31.1   Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Piercarlo Gramaglia  
31.2   Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Richard E. Mushrush
32.1   Certification of Piercarlo Gramaglia pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2   Certification of Richard E. Mushrush pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 33 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Telkonet, Inc.

Registrant

     
Date: May 16, 2022 By: /s/ Piercarlo Gramaglia
 

Piercarlo Gramaglia

Chief Executive Officer

(principal executive officer)

 

 

Date: May 16, 2022 By: /s/ Richard E. Mushrush
 

Richard E. Mushrush

Chief Financial Officer

(principal financial officer)

 

 

 

 34